These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


165 related items for PubMed ID: 21609197

  • 1. Diet composition and physical activity in overweight and obese premenopausal women with or without polycystic ovary syndrome.
    Álvarez-Blasco F, Luque-Ramírez M, Escobar-Morreale HF.
    Gynecol Endocrinol; 2011 Dec; 27(12):978-81. PubMed ID: 21609197
    [Abstract] [Full Text] [Related]

  • 2. Dietary intake, eating behaviors, and quality of life in women with polycystic ovary syndrome who are trying to conceive.
    Turner-McGrievy G, Davidson CR, Billings DL.
    Hum Fertil (Camb); 2015 Mar; 18(1):16-21. PubMed ID: 24921163
    [Abstract] [Full Text] [Related]

  • 3. Habitual dietary intake, eating pattern and physical activity of women with polycystic ovary syndrome.
    Barr S, Hart K, Reeves S, Sharp K, Jeanes YM.
    Eur J Clin Nutr; 2011 Oct; 65(10):1126-32. PubMed ID: 21629269
    [Abstract] [Full Text] [Related]

  • 4. Exploring factors related to changes in body composition, insulin sensitivity and aerobic capacity in response to a 12-week exercise intervention in overweight and obese women with and without polycystic ovary syndrome.
    Scott D, Harrison CL, Hutchison S, de Courten B, Stepto NK.
    PLoS One; 2017 Oct; 12(8):e0182412. PubMed ID: 28771628
    [Abstract] [Full Text] [Related]

  • 5. The effect of a hypocaloric diet with and without exercise training on body composition, cardiometabolic risk profile, and reproductive function in overweight and obese women with polycystic ovary syndrome.
    Thomson RL, Buckley JD, Noakes M, Clifton PM, Norman RJ, Brinkworth GD.
    J Clin Endocrinol Metab; 2008 Sep; 93(9):3373-80. PubMed ID: 18583464
    [Abstract] [Full Text] [Related]

  • 6. Insulin resistance and endocrine characteristics of the different phenotypes of polycystic ovary syndrome: a prospective study.
    Panidis D, Tziomalos K, Misichronis G, Papadakis E, Betsas G, Katsikis I, Macut D.
    Hum Reprod; 2012 Feb; 27(2):541-9. PubMed ID: 22144419
    [Abstract] [Full Text] [Related]

  • 7. Weight loss significantly reduces serum lipocalin-2 levels in overweight and obese women with polycystic ovary syndrome.
    Koiou E, Tziomalos K, Katsikis I, Kandaraki EA, Kalaitzakis E, Delkos D, Vosnakis C, Panidis D.
    Gynecol Endocrinol; 2012 Jan; 28(1):20-4. PubMed ID: 21756081
    [Abstract] [Full Text] [Related]

  • 8. A three-component cognitive behavioural lifestyle program for preconceptional weight-loss in women with polycystic ovary syndrome (PCOS): a protocol for a randomized controlled trial.
    Jiskoot G, Benneheij SH, Beerthuizen A, de Niet JE, de Klerk C, Timman R, Busschbach JJ, Laven JS.
    Reprod Health; 2017 Mar 06; 14(1):34. PubMed ID: 28264692
    [Abstract] [Full Text] [Related]

  • 9. The contribution of diet, physical activity and sedentary behaviour to body mass index in women with and without polycystic ovary syndrome.
    Moran LJ, Ranasinha S, Zoungas S, McNaughton SA, Brown WJ, Teede HJ.
    Hum Reprod; 2013 Aug 06; 28(8):2276-83. PubMed ID: 23771201
    [Abstract] [Full Text] [Related]

  • 10. Lifestyle intervention up-regulates gene and protein levels of molecules involved in insulin signaling in the endometrium of overweight/obese women with polycystic ovary syndrome.
    Ujvari D, Hulchiy M, Calaby A, Nybacka Å, Byström B, Hirschberg AL.
    Hum Reprod; 2014 Jul 06; 29(7):1526-35. PubMed ID: 24842895
    [Abstract] [Full Text] [Related]

  • 11. The role of orlistat combined with lifestyle changes in the management of overweight and obese patients with polycystic ovary syndrome.
    Panidis D, Tziomalos K, Papadakis E, Chatzis P, Kandaraki EA, Tsourdi EA, Katsikis I.
    Clin Endocrinol (Oxf); 2014 Mar 06; 80(3):432-8. PubMed ID: 23909452
    [Abstract] [Full Text] [Related]

  • 12. Diet, physical exercise and Orlistat administration increase serum anti-Müllerian hormone (AMH) levels in women with polycystic ovary syndrome (PCOS).
    Vosnakis C, Georgopoulos NA, Rousso D, Mavromatidis G, Katsikis I, Roupas ND, Mamali I, Panidis D.
    Gynecol Endocrinol; 2013 Mar 06; 29(3):242-5. PubMed ID: 23194076
    [Abstract] [Full Text] [Related]

  • 13. Effect of hypocaloric diet plus sibutramine treatment on hormonal and metabolic features in overweight and obese women with polycystic ovary syndrome: a randomized, 24-week study.
    Florakis D, Diamanti-Kandarakis E, Katsikis I, Nassis GP, Karkanaki A, Georgopoulos N, Panidis D.
    Int J Obes (Lond); 2008 Apr 06; 32(4):692-9. PubMed ID: 18071341
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. The impact of intensified exercise training on insulin resistance and fitness in overweight and obese women with and without polycystic ovary syndrome.
    Harrison CL, Stepto NK, Hutchison SK, Teede HJ.
    Clin Endocrinol (Oxf); 2012 Mar 06; 76(3):351-7. PubMed ID: 21711376
    [Abstract] [Full Text] [Related]

  • 17. Effects of exercise on insulin resistance and body composition in overweight and obese women with and without polycystic ovary syndrome.
    Hutchison SK, Stepto NK, Harrison CL, Moran LJ, Strauss BJ, Teede HJ.
    J Clin Endocrinol Metab; 2011 Jan 06; 96(1):E48-56. PubMed ID: 20926534
    [Abstract] [Full Text] [Related]

  • 18. Dietary glycemic index is associated with less favorable anthropometric and metabolic profiles in polycystic ovary syndrome women with different phenotypes.
    Graff SK, Mário FM, Alves BC, Spritzer PM.
    Fertil Steril; 2013 Oct 06; 100(4):1081-8. PubMed ID: 23830153
    [Abstract] [Full Text] [Related]

  • 19. Atherogenic changes in low-density lipoprotein particle profiles were not observed in non-obese women with polycystic ovary syndrome.
    Kim JJ, Chae SJ, Choi YM, Hwang KR, Song SH, Yoon SH, Kim SM, Ku SY, Kim SH, Kim JG, Moon SY.
    Hum Reprod; 2013 May 06; 28(5):1354-60. PubMed ID: 23477907
    [Abstract] [Full Text] [Related]

  • 20. Serum antimüllerian hormone in response to dietary management and/or physical exercise in overweight/obese women with polycystic ovary syndrome: secondary analysis of a randomized controlled trial.
    Nybacka Å, Carlström K, Fabri F, Hellström PM, Hirschberg AL.
    Fertil Steril; 2013 Oct 06; 100(4):1096-102. PubMed ID: 23876536
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 9.